Methylbenzethonium

Methylbenzethonium

SCHEMBL790480

Cc1cc(C(C)(C)CC(C)(C)C)ccc1OCCOCC[N+](C)(C)Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 1.00
TSHR P16473 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
CYP2D6 P10635 3/20 1.00
CYP1A2 P05177 1/20 1.00
SMN1; SMN2 Q16637 6/20 0.98
MEN1 O00255 5/20 0.98
KMT2A Q03164 5/20 0.98
ALDH1A1 P00352 4/20 0.98
USP2 O75604 4/20 0.98
TP53 P04637 4/20 0.98
APAF1 O14727 3/20 0.98
MAPT P10636 3/20 0.98
RAD52 P43351 3/20 0.98
HSP90AA1 P07900 1/20 0.98
UBE2N P61088 1/20 0.98
CYP3A4 P08684 4/20 0.72
HIF1A Q16665 3/20 0.72
ERBB2 P04626 2/20 0.72
FYN P06241 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylbenzethonium SCHEMBL29630503 1.00 LMNA (1.00) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL4418242 0.99 LMNA (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL7065208 0.99 LMNA (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL4413366 0.99 LMNA (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL136062 0.99 SMN1; SMN2 (1.00) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL29740116 0.98 SMN1; SMN2 (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL10984834 0.98 SMN1; SMN2 (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Hydrochloric Acid SCHEMBL11425941 0.92 SMN1; SMN2 (0.86) LMNATSHRTDP1CYP2D6CYP1A2
SCHEMBL14234861 0.90 LMNA (0.82) LMNATSHRTDP1CYP2D6CYP1A2
Benzethonium SCHEMBL122985 0.84 SMN1; SMN2 (1.00) LMNATSHRTDP1CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378439-B2 Compositions for tungsten etching inhibition BASF SE (DE) 2025-08-05 US claimed
US-20250017846-A1 TOPICAL ANALGESICS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-01-16 US claimed
US-20240292844-A1 Antimicrobial and Biological Active Polymer Composites and Related Methods, Materials, Coatings and Devices VACHON DAVID JOHN (US) 2024-09-05 US claimed
US-20240287264-A1 METHOD FOR PRODUCING A PLASTIC OBJECT WITH EMBEDDED QUATERNARY SALTS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 2024-08-29 US claimed
WO-2024170809-A1 METHOD FOR PREPARING MESOPOROUS SILICA NANO-RODS AND DERIVATIVE PRODUCTS UNIVERSITAT DE VALÈNCIA (ES) 2024-08-22 WO claimed
EP-4244319-B1 AQUEOUS ALKALINE ABRASIVE CLEANING COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2024-06-19 EP claimed
EP-4240820-B1 LIQUID AQUEOUS CLEANING COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2024-05-08 EP claimed
EP-4337733-A2 ANTIMICROBIAL AND BIOLOGICALLY ACTIVE POLYMER COMPOSITES AND RELATED METHODS, MATERIALS, COATINGS AND DEVICES Iasis Molecular Sciences, Inc. (US) 2024-03-20 EP claimed
EP-4247927-B1 AQUEOUS CLEANING COMPOSITION COMPRISING NON-IONIC SURFACTANT, QUATERNARY AMMONIUM COMPOUND, AND SEQUESTRANT UNILEVER IP HOLDINGS B V (NL) 2024-03-13 EP claimed
EP-2916820-B1 DELIVERY OF BIOLOGICALLY-ACTIVE AGENTS USING VOLATILE, HYDROPHOBIC SOLVENTS ROCHAL TECH LLC (US) 2023-10-11 EP claimed
EP-0784467-A1 UNITARY VAGINAL DOSAGE FORM USEFUL AS A LOCAL CONTRACEPTIVE AND/OR FOR COMBATTING SEXUALLY TRANSMITTED DISEASES AND/OR HIV LABORATOIRE INNOTHERA Société Anonyme (FR) 1997-07-23 EP claimed
US-5567716-A FOR THE THERAPEUTIC TREATMENT OF CUTANEOUS PATHOLOGIES LIFEGROUP S.P.A. (IT) 1996-10-22 US claimed
EP-0732916-A1 VIRACIDAL, BACTERICIDAL AND SPERMICIDAL VAGINAL SUPPOSITORY LAFOR LABORATORIES LIMITED (US) 1996-09-25 EP claimed
WO-1996019195-A1 UNITARY VAGINAL DOSAGE FORM USEFUL AS A LOCAL CONTRACEPTIVE AND/OR FOR COMBATTING SEXUALLY TRANSMITTED DISEASES AND/OR HIV LABORATOIRE INNOTHERA (FR) 1996-06-27 WO claimed
WO-1995015157-A1 VIRACIDAL, BACTERICIDAL AND SPERMICIDAL VAGINAL SUPPOSITORY LAFOR LABORATORIES LIMITED (US) 1995-06-08 WO claimed
EP-0311344-B1 Disposable absorbent articles for incontinent individuals PROCTER & GAMBLE (US) 1995-01-04 EP claimed
EP-0599188-A1 Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity LIFEGROUP S.p.A. (IT) 1994-06-01 EP claimed
EP-0520160-A1 Process for antimicrobial treatment of polyurethane BOC HEALTH CARE, Inc. (US) 1992-12-30 EP claimed
US-4877617-A COATING WITH SOLUTION OF QUATERNARY AMMONIUM SALT OF ALGINIC ACID OR CMC IN REMOVABLE SOLVENT; HOUSEHOLDS, MEDICINE, INDUSTRY DAICEL CHEMICAL INDUSTRIES LTD. (JP) 1989-10-31 US claimed
EP-0090587-B1 PAROMOMYCIN COMPOSITIONS FOR TOPICAL TREATMENT OF CUTANEOUS LEISHMANIASIS ORVET B.V. (NL) 1985-08-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250017846-A1 TOPICAL ANALGESICS OPRK1, OPRL1, OPRM1 LMNA 4719/4885TSHR 2969/4885TDP1 1759/4885
US-20240292844-A1 Antimicrobial and Biological Active Polymer Composites and Related Methods, Materials, Coatings and Devices CD81, PHOSPHO1, SLC11A2 LMNA 2951/4885TSHR 4291/4885TDP1 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.